A Parkinson's Disease programme at Stem Plus in Sofia is €3,000–€8,000, versus roughly €18,000–€35,000 in the United States. About 11.5h from New York, inside the EU, visa-free.
If you are researching Parkinson's Disease treatment from the United States, the obstacle is usually access or cost: standard options have plateaued, and regenerative therapy at home runs to €18,000–€35,000. Stem Plus offers the same European GMP standard for a fraction of that — and an easy, mostly visa-free trip.
Neural-lineage and MSC protocols aim to support dopaminergic pathways and reduce neuro-inflammation, complementing levodopa-based care. It is delivered under a physician-led protocol and designed to complement your existing care.
| United States (home) | Stem Plus · EU | |
|---|---|---|
| Parkinson's Disease treatment | €18,000–€35,000 | €3,000–€8,000 |
| Regulation | varies | EU · GMP |
| Flight to Sofia | 11.5h from New York | — |
This note is general information for planning, not legal or medical advice. Confirm entry rules for your nationality before booking.
Cost ranges are indicative market figures for planning, not quotes.
GMP-сертифицированная регенеративная медицина в сердце ЕС — от €3 000–8 000, доля от цен США или Германии. Индивидуальные протоколы для пациентов из 50+ стран.
Бесплатная оценка врача